Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Fatigue and Comorbidities in Multiple Sclerosis.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Dimethyl fumarate protection against collagen II degradation.
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Myelin Gordon Research Conference
Immunology 2016
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Diagnosis and treatment of hyponatraemia.
Rare onset symptoms in multiple sclerosis.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Clinical Epigenetics International Meeting
EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Pages